Rob Carlson

Trillium Corp. invests in real estate and forestry. The company also provides land for preservation and scientific research, community parks, bald eagle communal night roosts, heron habitats, and Peregrine falcon roosting sites. Its other assets include business parks and office and medical buildings. The company was founded by David R. Syre and Kay E. Syre in 1974 and is headquartered in Bellingham, WA.

New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY.

The American Association of Blood Banks is a professional organization dedicated to advancing the field of transfusion medicine and cellular therapies. The non-profit company is based in Bethesda, MD and has subsidiaries in Puerto Rico. The association provides accreditation and certification programs for blood banks and transfusion services, as well as educational resources and advocacy efforts.

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

Wave Biotech LLC develops and manufactures process equipment for the pharmaceutical and biotechnology industry. The company was founded in 1998 by Vijay Singh and is headquartered in Somerset, NJ

Humco, Inc. operates hospitals and healthcare centers. Its services include total preparation, processing, and arrangement, transportation and specialized international insurance programs. The company is headquartered in Baltimore, MD.

Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY.

International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States.

Hackensack University Medical Center's standing as one of New Jersey's and the nation's healthcare leaders are driven by a commitment to quality. At the firm quality means always striving to deliver the best medicine to its patients. It means always re-evaluating the delivery of healthcare to ensure that high standards are achieved. It means never turning away from a community need, but instead redoubling its efforts and commitment to respond to those needs.

The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet.

Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Topgolf, Inc. provides game entertainment complex. It features climate-controlled hitting bays, event spaces for groups of all sizes, free club rentals, touch screen game activator, and food and drink menu. The company was founded in 2000 and is headquartered in Dallas, TX.

FloDesign Sonics, Inc. provides acoustic technology for separations and filtrations. It develops technology that sound vibrations to filter fluids including blood. The firm also develops filter-less acoustophoretic separation technology, and separate multiple types of particles of varying sizes including water and oil, blood cells, CHO cells, emulsified oils, algae, metals, and bacteria. The company was founded by Bart Lipkens, Stanley Kowalski III, Walter Presz and Louis Masi in 2009 and is headquartered in Wilbraham, MA.

Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.

Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA.

Microbyre, Inc. develops biotechnologies. It converts non-model species into tractable strains within the techniques from model organisms. The company was founded by Sarah Richardson, Jeff Anderson, and Margaret Brown in 2017 and is headquartered in Berkeley, CA.

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and aims to deliver more efficacious and safer treatments for patients. The CEO of the company is Sergio G. Duron.

Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.